Breaking news

Nvidia Unleashes Evo 2: The AI Powerhouse For Genetic Research

Nvidia, the U.S.-based AI chip giant, has unveiled Evo 2, the most advanced artificial intelligence system dedicated to biomolecular science. Built-in collaboration with Stanford University and the nonprofit Arc Institute, Evo 2 is set to redefine genetic research, accelerating breakthroughs in medicine and biotechnology.

AI Meets Genomics

Powered by Nvidia DGX Cloud on Amazon Web Services (AWS), Evo 2 is designed to decode the complexities of DNA, RNA, and proteins across a vast spectrum of species. With a dataset of nearly 9 trillion nucleotides—the fundamental units of DNA and RNA—this AI model is poised to revolutionize biological research. Its capabilities extend to predicting protein structures, identifying novel molecules for healthcare and industrial applications, and analyzing the effects of genetic mutations.

Evo 2 is now the largest publicly available AI model for genomic data, offering scientists an unprecedented tool for biological discovery. Researchers can leverage Nvidia’s NIM microservice to generate biological sequences and fine-tune the model using their proprietary datasets via the open-source Nvidia BioNeMo Framework.

Game-Changing Potential

“Evo 2 represents a major milestone for generative genomics,” said Patrick Hsu, cofounder of Arc Institute and assistant professor of bioengineering at UC Berkeley. “By deepening our understanding of life’s fundamental building blocks, we can unlock new possibilities in healthcare and environmental science that were once unimaginable.”

Brian Hie, assistant professor of chemical engineering at Stanford and faculty fellow at the Dieter Schwarz Foundation Stanford Data Science, echoed this sentiment: “With Evo 2, complex biological design becomes more accessible, allowing researchers to develop groundbreaking innovations in a fraction of the time.”

Market Reaction

Despite the breakthrough, Nvidia’s stock dipped 0.2% in after-hours trading on Wednesday, settling at $139 per share, with a market capitalization of $3.4 trillion. However, as AI-driven biotech advances continue to gain momentum, Nvidia’s role in shaping the future of medicine and genomics remains stronger than ever.

Cyprus Crypto Users Face New Risks As MiCA Rules Take Effect

Why Investors Need To Check The Company Behind Their Crypto Platform

Crypto users in Cyprus are being urged to verify exactly which company holds their assets after the EU’s Markets in Crypto-Assets Regulation (MiCA) transition period ended on July 1, 2026.

MiCA rules for crypto-asset service providers have applied since December 2024, but Cyprus allowed companies operating under its previous national framework to continue temporarily. CySEC required providers wishing to remain in the market to apply by February 27, 2026.

The end of the transition means that appearing on an old national register is no longer enough. Investors must check the specific legal entity providing the service and the activities it is authorised to perform.

Two Regulatory Routes

CySEC maintains separate registers for providers authorised under Article 63 and companies using the Article 60 notification route.

The lists should not simply be treated as a count of licensed crypto exchanges. Providers have different regulatory statuses and may be authorised for different services, including custody, transfers, exchanges or operating trading platforms.

Companies authorised elsewhere in the EU can also serve Cypriot customers through MiCA passporting. Investors should therefore check the wider ESMA register.

Familiar Brands Can Still Be Used In Scams

MiCA authorisation applies to a specific legal entity, not automatically to every website, subsidiary or service using the same brand. Fraudsters can copy a legitimate company’s name, logo and licence number while changing its website or payment details.

The regulatory transition creates another opportunity for scammers. They can imitate legitimate notices about account closures or transfers and claim that customers must urgently move their assets to a new “regulated” platform.

In its July announcement, CySEC warned that customers using unauthorised providers do not receive MiCA protections and advised investors to verify providers through ESMA.

A Wider European Shake-Up

The changes affect the broader European crypto market. VASPnet estimated that more than 1,700 unlicensed crypto companies could face closure, relocation or restructuring after the transition period.

ESMA’s register contained 323 authorised providers at the end of July, while TRM Labs identified 1,343 operating providers in the European Economic Area on July 1, including 281 with MiCA authorisation. The different figures reflect different methodologies, but point to a substantial number of providers operating without the new authorisation.

ESMA instructed unauthorised companies to stop accepting new EU customers, opening accounts and marketing their services, while allowing limited activity needed for an orderly withdrawal.

What Investors Should Check

MiCA introduces common requirements for areas such as governance, disclosures and safeguarding client assets, but it does not make crypto investments risk-free.

For Cyprus users, the key questions are which legal entity provides the service, what it is authorised to do and whether the website or contact details are genuine.

Requests to transfer assets urgently, pay recovery fees, reveal private keys or install remote-access software should be treated as red flags. MiCA may bring greater clarity to the market, but the transition has also created a new opportunity for criminals to exploit a very real regulatory change.

Uol
The Future Forbes Realty Global Properties
Aretilaw firm
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter